患者与医生对头颈癌研究入组的看法
本研究采用前瞻性多方法定性定量嵌入式伦理方案,在单机构NCI指定学术癌症中心对参与精准头颈肿瘤测序方案的病人和医生进行配对调查与半结构化访谈(116名调查病人参与者,应答率82%,18名受访者)。结果显示参与者普遍对入组研究热情高涨,既为帮助未来患者也为回馈社区;他们依赖并信任癌症医生关于参与决策的信息,但医生和患者对各自在决策过程中影响力的报告存在不一致。临床医生强调分离临床与研究知情同意过程的重要性,而患者未描述这种紧张。
要点
- 患者对头颈癌研究入组普遍热情,动机包括帮助未来患者和回馈社区。
- 患者依赖并信任癌症医生关于研究参与决策的信息。
- 医生和患者对决策影响力的报告存在 paradoxically 不一致。
核心结论
- 在精准肿瘤学时代,临床医生、科学家和患者之间的关系在个体化和情境化癌症研究中发挥更大作用。
- 数据朝着尊重和保护头颈转化肿瘤学患者参与者的最终目标迈进。
研究设计与样本
- 前瞻性多方法定性和定量嵌入式伦理协议。
- 单机构国家癌症研究所指定的学术癌症中心。
- 多方法研究使用配对调查和半结构化访谈,涉及参与前瞻性精准头颈肿瘤测序协议的病人和提供者(116名调查病人参与者,应答率82%),18名受访者。
主要发现
- 参与者通常对入组研究充满热情,既为帮助未来患者也为回馈社区。
- 他们描述依赖癌症医生的信息并信任其关于参与研究的决定。
- paradoxically,医生和患者报告各自在决策过程中的影响存在不一致。
- 临床医生强调分离临床和研究知情同意过程的重要性,尽管患者未描述这种紧张。
临床怎么用
- 临床医生应认识到患者对医生的信任在研究入组决策中的核心作用。
- 在头颈癌研究中,需注意医生和患者对决策影响力感知的差异。
- 临床医生应强调并实践临床与研究知情同意过程的分离。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The advent of precision oncology complicates how clinicians and participants understand how clinical care and research interface. Here we examine how key stakeholders perceive the utility of, and evaluate the decision to participate in, genomic sequencing head and neck cancer research. The goal of this study was to highlight unique considerations for our community as this type of research proliferates across the country. STUDY DESIGN: Prospective multimethod qualitative and quantitative embedded ethics protocol. SETTING: Single-institution National Cancer Institute-designated academic cancer center. SUBJECTS AND METHODS: Multimethod study using paired surveys and semistructured interviews among patients and providers involved in a prospective precision head and neck oncology sequencing protocol (116 survey patient-participants, response rate 82%) with 18 interviewees. RESULTS: Participants were generally enthusiastic about enrollment in research, both to help future patients and as a way of giving back to the community. They described reliance on information from and trust in their cancer doctor regarding the decision to participate in research, but paradoxically there was discordance in how doctors and patients reported their respective influence in the decision-making process. Clinicians also stressed the importance in separating clinical and research-informed consent processes, although patients did not describe this tension. CONCLUSION: As we enter an era of increasing personalized medicine and targeted therapies, the relationship between clinicians, scientists, and patients plays a larger role in how we individualize and contextualize cancer research. Our data are another step toward the ultimate goal of respecting and protecting patients as participants in head and neck translational oncology.
引用
- Shuman AG, Gornick MC, Brummel C, et al. Patient and Provider Perspectives Regarding Enrollment in Head and Neck Cancer Research. Otolaryngol Head Neck Surg. 2019. PMID: 31818193. doi:10.1177/0194599819889976
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。